News

Can bariatric surgery ease psoriasis too?

Posted on: 06/11/2015 - 18:53

LOS ANGELES – A provocative study opens the door for psoriasis and psoriatic arthritis to be added to the growing list of benefits following bariatric surgery. “Although the natural history of...

Field of Interest: Dermatology
Type: News Item

Busting eczema treatment myths: applying the evidence

Posted on: 06/11/2015 - 16:33

LAS VEGAS – In the treatment of eczema, the gap between evidence and practice can be broad. Dermatologists who treat atopic dermatitis confront many challenges – patients may be severely atopic,...

Field of Interest: Dermatology
Type: News Item

Antidepressants for functional dyspepsia

Posted on: 05/11/2015 - 15:08

Functional, a.k.a. “nonulcer,” dyspepsia is a challenging diagnosis and likely afflicts many more patients than we have identified in our practices. Functional dyspepsia (FD) is defined by the...

Field of Interest: Gastroentero...
Type: News Item

EADV: Venous leg ulcers herald increased cancer risk

Posted on: 05/11/2015 - 14:48

COPENHAGEN – Patients with venous leg ulcers have an increased risk of occult cancer – especially hematologic and immune-related malignancies, according to a Danish nationwide cohort study. The risk...

Field of Interest: Oncology
Type: News Item

EADV: Venous leg ulcers herald increased cancer risk

Posted on: 05/11/2015 - 14:48

COPENHAGEN – Patients with venous leg ulcers have an increased risk of occult cancer – especially hematologic and immune-related malignancies, according to a Danish nationwide cohort study. The risk...

Field of Interest: Dermatology
Type: News Item

Raloxifene ineffective for treating AD patients

Posted on: 04/11/2015 - 21:36

Treatment with the estrogen-receptor modulator raloxifene does not significantly improve cognitive function in women with Alzheimer’s disease (AD), results of a U.S. randomized, double-blind,...

Field of Interest: Pulmonology
Type: News Item

Raloxifene ineffective for treating AD patients

Posted on: 04/11/2015 - 21:36

Treatment with the estrogen-receptor modulator raloxifene does not significantly improve cognitive function in women with Alzheimer’s disease (AD), results of a U.S. randomized, double-blind,...

Field of Interest: Geriatrics
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness